Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News St Jude Medical receives approval for ShockGuard defibrillation technology

St Jude Medical receives approval for ShockGuard defibrillation technology

20th April 2011

St Jude Medical has been granted regulatory approval for a new technology offering that helps to improve the safety of defibrillation procedures.

The company has received European CE mark and US Food and Drug Administration backing for the new ShockGuard technology, which is designed for use with its Unify cardiac resynchronisation therapy defibrillators and Fortify implantable cardioverter defibrillators.

With the new system installed, advanced DecisionTx sensing technology is able to discriminate between rhythms that require defibrillation therapy and those that do not, avoiding sensing unwanted signals and reducing inappropriate and unnecessary shocks.

The device has demonstrated its effectiveness in clinical studies and has been identified as a new method of addressing a key challenge in defibrillation.

Dr Eric Fain, president of the St Jude Medical cardiac rhythm management division, said: "DecisionTx represents the first step of our new ShockGuard technology and further supports our commitment to deliver more control to physicians worldwide."

This comes in the same month that St Jude also received European approval for its Accent MRI pacemaker device and accompanying Tendril MRI lead.ADNFCR-8000103-ID-800507571-ADNFCR

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.